This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of the Witwatersrand. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Bibi F Choonara: Innovator in Oral Pharmaceutical Dosage Forms
Introduction
Bibi F Choonara is a notable inventor based in Gauteng, South Africa. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative oral dosage forms. His work focuses on enhancing the delivery of peptides and proteins through advanced pharmaceutical formulations.
Latest Patents
Bibi F Choonara holds a patent for an "Oral pharmaceutical dosage form for the delivery of a peptide and/or protein." This invention relates to a thermoresponsive eutectic composition that is solid at room temperature and fluid at body temperature. The dosage form includes a crosslinking agent and an active pharmaceutical ingredient (API) to create an API loaded region. A porous polymeric composition surrounds this region, protecting the API in the stomach while allowing controlled release in the intestine.
Career Highlights
Choonara is affiliated with the University of the Witwatersrand in Johannesburg, where he continues to advance research in pharmaceutical sciences. His innovative approach to drug delivery systems has garnered attention in the scientific community.
Collaborations
Bibi F Choonara has collaborated with notable colleagues, including Viness Pillay and Lisa Claire Du Toit, who contribute to his research endeavors.
Conclusion
Bibi F Choonara's work in oral pharmaceutical dosage forms exemplifies the intersection of innovation and healthcare. His contributions are paving the way for more effective drug delivery systems, ultimately benefiting patients worldwide.